Trigger Point Injections for Headache Disorders: Expert Consensus Methodology and Narrative Review
dc.contributor.author | Robbins, Matthew S. | en_US |
dc.contributor.author | Kuruvilla, Deena | en_US |
dc.contributor.author | Blumenfeld, Andrew | en_US |
dc.contributor.author | Charleston, Larry | en_US |
dc.contributor.author | Sorrell, Michael | en_US |
dc.contributor.author | Robertson, Carrie E. | en_US |
dc.contributor.author | Grosberg, Brian M. | en_US |
dc.contributor.author | Bender, Steven D. | en_US |
dc.contributor.author | Napchan, Uri | en_US |
dc.contributor.author | Ashkenazi, Avi | en_US |
dc.date.accessioned | 2014-11-04T16:35:45Z | |
dc.date.available | WITHHELD_12_MONTHS | en_US |
dc.date.available | 2014-11-04T16:35:45Z | |
dc.date.issued | 2014-10 | en_US |
dc.identifier.citation | Robbins, Matthew S.; Kuruvilla, Deena; Blumenfeld, Andrew; Charleston, Larry; Sorrell, Michael; Robertson, Carrie E.; Grosberg, Brian M.; Bender, Steven D.; Napchan, Uri; Ashkenazi, Avi (2014). "Trigger Point Injections for Headache Disorders: Expert Consensus Methodology and Narrative Review." Headache: The Journal of Head and Face Pain (9): 1441-1459. | en_US |
dc.identifier.issn | 0017-8748 | en_US |
dc.identifier.issn | 1526-4610 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/109332 | |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.subject.other | Migraine | en_US |
dc.subject.other | Trigger Point Injection | en_US |
dc.subject.other | Headache | en_US |
dc.subject.other | Local Anesthetic | en_US |
dc.subject.other | Tension‐Type | en_US |
dc.subject.other | Myofascial Pain | en_US |
dc.title | Trigger Point Injections for Headache Disorders: Expert Consensus Methodology and Narrative Review | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Medicine (General) | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/109332/1/head12442.pdf | |
dc.identifier.doi | 10.1111/head.12442 | en_US |
dc.identifier.source | Headache: The Journal of Head and Face Pain | en_US |
dc.identifier.citedreference | Tfelt‐Hansen P, Pascual J, Ramadan N, et al. Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators. Cephalalgia. 2012; 32: 6 ‐ 38. | en_US |
dc.identifier.citedreference | Abboud J, Marchand AA, Sorra K, Descarreaux M. Musculoskeletal physical outcome measures in individuals with tension‐type headache: A scoping review. Cephalalgia. 2013; 33: 1319 ‐ 1336. | en_US |
dc.identifier.citedreference | Shafer N. Pneumothorax following “trigger point” injection. JAMA. 1970; 213: 1193. | en_US |
dc.identifier.citedreference | Paik NC, Seo JW. CT‐guided needle aspiration of pneumothorax from a trigger point injection. Pain Med. 2011; 12: 837 ‐ 841. | en_US |
dc.identifier.citedreference | Botwin KP, Patel BC. Electromyographically guided trigger point injections in the cervicothoracic musculature of obese patients: A new and unreported technique. Pain Physician. 2007; 10: 753 ‐ 756. | en_US |
dc.identifier.citedreference | Botwin KP, Sharma K, Saliba R, Patel BC. Ultrasound‐guided trigger point injections in the cervicothoracic musculature: A new and unreported technique. Pain Physician. 2008; 11: 885 ‐ 889. | en_US |
dc.identifier.citedreference | Fernandez‐de‐Las‐Penas C, Ge HY, Alonso‐Blanco C, Gonzalez‐Iglesias J, Arendt‐Nielsen L. Referred pain areas of active myofascial trigger points in head, neck, and shoulder muscles, in chronic tension type headache. J Bodyw Mov Ther. 2010; 14: 391 ‐ 396. | en_US |
dc.identifier.citedreference | Fernandez‐de‐Las‐Penas C, Simons D, Cuadrado ML, Pareja J. The role of myofascial trigger points in musculoskeletal pain syndromes of the head and neck. Curr Pain Headache Rep. 2007; 11: 365 ‐ 372. | en_US |
dc.identifier.citedreference | Giamberardino MA, Tafuri E, Savini A, et al. Contribution of myofascial trigger points to migraine symptoms. J Pain. 2007; 8: 869 ‐ 878. | en_US |
dc.identifier.citedreference | Alvarez DJ, Rockwell PG. Trigger points: Diagnosis and management. Am Fam Physician. 2002; 65: 653 ‐ 660. | en_US |
dc.identifier.citedreference | Weiss LD. Easy Injections. Philadelphia: Butterworth‐Heinemann/Elsevier; 2007. | en_US |
dc.identifier.citedreference | Reeves JL, Jaeger B, Graff‐Radford SB. Reliability of the pressure algometer as a measure of myofascial trigger point sensitivity. Pain. 1986; 24: 313 ‐ 321. | en_US |
dc.identifier.citedreference | Fischer AA. Pressure algometry over normal muscles. Standard values, validity and reproducibility of pressure threshold. Pain. 1987; 30: 115 ‐ 126. | en_US |
dc.identifier.citedreference | Hong C‐Z. Considerations and recommendations regarding myofascial trigger point injection. J Musculoskelet Pain. 1994; 2: 29 ‐ 59. | en_US |
dc.identifier.citedreference | Cheng J, Abdi S. Complications of joint, tendon, and muscle injections. Tech Reg Anesth Pain Manag. 2007; 11: 141 ‐ 147. | en_US |
dc.identifier.citedreference | Rosenberg PH, Veering BT, Urmey WF. Maximum recommended doses of local anesthetics: A multifactorial concept. Reg Anesth Pain Med. 2004; 29: 564 ‐ 575, discussion 524. | en_US |
dc.identifier.citedreference | Becker DE, Reed KL. Local anesthetics: Review of pharmacological considerations. Anesth Prog. 2012; 59: 90 ‐ 101, quiz 102‐103. | en_US |
dc.identifier.citedreference | Nelson LS, Hoffman RS. Intrathecal injection: Unusual complication of trigger‐point injection therapy. Ann Emerg Med. 1998; 32: 506 ‐ 508. | en_US |
dc.identifier.citedreference | Elias M. Cervical epidural abscess following trigger point injection. J Pain Symptom Manage. 1994; 9: 71 ‐ 72. | en_US |
dc.identifier.citedreference | Scott NA, Guo B, Barton PM, Gerwin RD. Trigger point injections for chronic non‐malignant musculoskeletal pain: A systematic review. Pain Med. 2009; 10: 54 ‐ 69. | en_US |
dc.identifier.citedreference | Cagnie B, Dewitte V, Barbe T, Timmermans F, Delrue N, Meeus M. Physiologic effects of dry needling. Curr Pain Headache Rep. 2013; 17: 348. | en_US |
dc.identifier.citedreference | Tough EA, White AR, Cummings TM, Richards SH, Campbell JL. Acupuncture and dry needling in the management of myofascial trigger point pain: A systematic review and meta‐analysis of randomised controlled trials. Eur J Pain. 2009; 13: 3 ‐ 10. | en_US |
dc.identifier.citedreference | Leroux E, Valade D, Taifas I, et al. Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: A randomised, double‐blind, placebo‐controlled trial. Lancet Neurol. 2011; 10: 891 ‐ 897. | en_US |
dc.identifier.citedreference | Ambrosini A, Vandenheede M, Rossi P, et al. Suboccipital injection with a mixture of rapid‐ and long‐acting steroids in cluster headache: A double‐blind placebo‐controlled study. Pain. 2005; 118: 92 ‐ 96. | en_US |
dc.identifier.citedreference | Chen JT, Chung KC, Hou CR, Kuan TS, Chen SM, Hong CZ. Inhibitory effect of dry needling on the spontaneous electrical activity recorded from myofascial trigger spots of rabbit skeletal muscle. Am J Phys Med Rehabil. 2001; 80: 729 ‐ 735. | en_US |
dc.identifier.citedreference | Sato A, Sato Y, Shimura M, Uchida S. Calcitonin gene‐related peptide produces skeletal muscle vasodilation following antidromic stimulation of unmyelinated afferents in the dorsal root in rats. Neurosci Lett. 2000; 283: 137 ‐ 140. | en_US |
dc.identifier.citedreference | Chu J, Schwartz I. The muscle twitch in myofascial pain relief: Effects of acupuncture and other needling methods. Electromyogr Clin Neurophysiol. 2002; 42: 307 ‐ 311. | en_US |
dc.identifier.citedreference | Niddam DM, Chan RC, Lee SH, Yeh TC, Hsieh JC. Central modulation of pain evoked from myofascial trigger point. Clin J Pain. 2007; 23: 440 ‐ 448. | en_US |
dc.identifier.citedreference | Sahai‐Srivastava S, Subhani D. Adverse effect profile of lidocaine injections for occipital nerve block in occipital neuralgia. J Headache Pain. 2010; 11: 519 ‐ 523. | en_US |
dc.identifier.citedreference | Ashkenazi A, Blumenfeld A, Napchan U, et al. Peripheral nerve blocks and trigger point injections in headache management – a systematic review and suggestions for future research. Headache. 2010; 50: 943 ‐ 952. | en_US |
dc.identifier.citedreference | Simons DG, Travell JG, Simons LS. Myofascial Pain and Dysfunction: The Trigger Point Manual, Vol. 1, 2nd edn, Upper Half of Body. Baltimore: Lippincott Williams & Wilkins; 1999. | en_US |
dc.identifier.citedreference | Sorrell MR. The physical examination of migraine. Curr Pain Headache Rep. 2006; 10: 350 ‐ 354. | en_US |
dc.identifier.citedreference | Graff‐Radford SB. Myofascial pain: Diagnosis and management. Curr Pain Headache Rep. 2004; 8: 463 ‐ 467. | en_US |
dc.identifier.citedreference | Ge HY, Fernandez‐de‐Las‐Penas C, Yue SW. Myofascial trigger points: Spontaneous electrical activity and its consequences for pain induction and propagation. Chin Med. 2011; 6: 13. | en_US |
dc.identifier.citedreference | Shah JP, Phillips TM, Danoff JV, Gerber LH. An in vivo microanalytical technique for measuring the local biochemical milieu of human skeletal muscle. J Appl Physiol (1985). 2005; 99: 1977 ‐ 1984. | en_US |
dc.identifier.citedreference | Alonso‐Blanco C, de‐la‐Llave‐Rincon AI, Fernandez‐de‐las‐Penas C. Muscle trigger point therapy in tension‐type headache. Expert Rev Neurother. 2012; 12: 315 ‐ 322. | en_US |
dc.identifier.citedreference | Fernandez‐de‐Las‐Penas C, Alonso‐Blanco C, Cuadrado ML, Gerwin RD, Pareja JA. Myofascial trigger points and their relationship to headache clinical parameters in chronic tension‐type headache. Headache. 2006; 46: 1264 ‐ 1272. | en_US |
dc.identifier.citedreference | Calandre EP, Hidalgo J, Garcia‐Leiva JM, Rico‐Villademoros F. Trigger point evaluation in migraine patients: An indication of peripheral sensitization linked to migraine predisposition? Eur J Neurol. 2006; 13: 244 ‐ 249. | en_US |
dc.identifier.citedreference | Calandre EP, Hidalgo J, Garcia‐Leiva JM, Rico‐Villademoros F, Delgado‐Rodriguez A. Myofascial trigger points in cluster headache patients: A case series. Head Face Med. 2008; 4: 32. | en_US |
dc.identifier.citedreference | Blumenfeld A, Ashkenazi A, Grosberg B, et al. Patterns of use of peripheral nerve blocks and trigger point injections among headache practitioners in the USA: Results of the American Headache Society Interventional Procedure Survey (AHS‐IPS). Headache. 2010; 50: 937 ‐ 942. | en_US |
dc.identifier.citedreference | Peripheral Nerve Blocks and Other Interventional Procedures for Headache and Face Pain Section. In: American Headache Society. http://www.americanheadachesociety.org/members/special_interest_sections/peripheral_nerve_blocks_and_other_interventional_procedures_for_headache_and_face_pain. Accessed August 9, 2013. | en_US |
dc.identifier.citedreference | Blumenfeld A, Ashkenazi A, Napchan U, et al. Expert consensus recommendations for the performance of peripheral nerve blocks for headaches – a narrative review. Headache. 2013; 53: 437 ‐ 446. | en_US |
dc.identifier.citedreference | Celik D, Mutlu EK. Clinical implication of latent myofascial trigger point. Curr Pain Headache Rep. 2013; 17: 353. | en_US |
dc.identifier.citedreference | Karadas O, Gul HL, Inan LE. Lidocaine injection of pericranial myofascial trigger points in the treatment of frequent episodic tension‐type headache. J Headache Pain. 2013; 14: 44. | en_US |
dc.identifier.citedreference | Harden RN, Cottrill J, Gagnon CM, et al. Botulinum toxin A in the treatment of chronic tension‐type headache with cervical myofascial trigger points: A randomized, double‐blind, placebo‐controlled pilot study. Headache. 2009; 49: 732 ‐ 743. | en_US |
dc.identifier.citedreference | Karadas O, Inan LE, Ulas U, Odabasi Z. Efficacy of local lidocaine application on anxiety and depression and its curative effect on patients withchronic tension‐type headache. Eur Neurol. 2013; 70: 95 ‐ 101. | en_US |
dc.identifier.citedreference | Fernandez‐de‐Las‐Penas C, Cuadrado ML, Pareja JA. Myofascial trigger points, neck mobility and forward head posture in unilateral migraine. Cephalalgia. 2006; 26: 1061 ‐ 1070. | en_US |
dc.identifier.citedreference | Ashkenazi A, Young WB. The effects of greater occipital nerve block and trigger point injection on brush allodynia and pain in migraine. Headache. 2005; 45: 350 ‐ 354. | en_US |
dc.identifier.citedreference | Garcia‐Leiva JM, Hidalgo J, Rico‐Villademoros F, Moreno V, Calandre EP. Effectiveness of ropivacaine trigger points inactivation in the prophylactic management of patients with severe migraine. Pain Med. 2007; 8: 65 ‐ 70. | en_US |
dc.identifier.citedreference | Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013; 33: 629 ‐ 808. | en_US |
dc.identifier.citedreference | Baron EP, Cherian N, Tepper SJ. Role of greater occipital nerve blocks and trigger point injections for patients with dizziness and headache. Neurologist. 2011; 17: 312 ‐ 317. | en_US |
dc.identifier.citedreference | Packard RC. The relationship of neck injury and post‐traumatic headache. Curr Pain Headache Rep. 2002; 6: 301 ‐ 307. | en_US |
dc.identifier.citedreference | Marcus DA, Scharff L, Mercer S, Turk DC. Musculoskeletal abnormalities in chronic headache: A controlled comparison of headache diagnostic groups. Headache. 1999; 39: 21 ‐ 27. | en_US |
dc.identifier.citedreference | Tfelt‐Hansen P, Lous I, Olesen J. Prevalence and significance of muscle tenderness during common migraine attacks. Headache. 1981; 21: 49 ‐ 54. | en_US |
dc.identifier.citedreference | Jensen K, Tuxen C, Olesen J. Pericranial muscle tenderness and pressure‐pain threshold in the temporal region during common migraine. Pain. 1988; 35: 65 ‐ 70. | en_US |
dc.identifier.citedreference | Olesen J. Some clinical features of the acute migraine attack. An analysis of 750 patients. Headache. 1978; 18: 268 ‐ 271. | en_US |
dc.identifier.citedreference | Ferguson LW, Gerwin R. Clinical Mastery in the Treatment of Myofascial Pain. Philadelphia: Lippincott Williams & Wilkins; 2005. | en_US |
dc.identifier.citedreference | Gerwin RD, Shannon S, Hong CZ, Hubbard D, Gevirtz R. Interrater reliability in myofascial trigger point examination. Pain. 1997; 69: 65 ‐ 73. | en_US |
dc.identifier.citedreference | Simons DG, Mense S. [Diagnosis and therapy of myofascial trigger points]. Schmerz. 2003; 17: 419 ‐ 424. | en_US |
dc.identifier.citedreference | Leone M, D'Amico D, Moschiano F, Farinotti M, Filippini G, Bussone G. Possible identification of cervicogenic headache among patients with migraine: An analysis of 374 headaches. Headache. 1995; 35: 461 ‐ 464. | en_US |
dc.identifier.citedreference | Sjaastad O, Fredriksen TA, Pfaffenrath V. Cervicogenic headache: Diagnostic criteria. Headache. 1990; 30: 725 ‐ 726. | en_US |
dc.identifier.citedreference | Biondi DM. Cervicogenic headache: A review of diagnostic and treatment strategies. J Am Osteopath Assoc. 2005; 105: 16S ‐ 22S. | en_US |
dc.identifier.citedreference | Yanguela J, Pareja JA, Lopez N, Sanchez Del Rio M. Trochleitis and migraine headache. Neurology. 2002; 58: 802 ‐ 805. | en_US |
dc.identifier.citedreference | Fernandez‐de‐las‐Penas C, Alonso‐Blanco C, Cuadrado ML, Pareja JA. Forward head posture and neck mobility in chronic tension‐type headache: A blinded, controlled study. Cephalalgia. 2006; 26: 314 ‐ 319. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.